West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 615,500 | 439,100 | 337,400 | 235,900 | 203,000 |
| Receivables | 385,300 | 319,300 | 288,200 | 253,200 | 200,500 |
| Inventories | 321,300 | 235,700 | 214,500 | 215,200 | 199,300 |
| Other current assets | 51,600 | 64,600 | 54,300 | 39,200 | 39,100 |
| TOTAL | $1,373,700 | $1,058,700 | $894,400 | $743,500 | $641,900 |
| Non-Current Assets | |||||
| PPE Net | 943,200 | 839,300 | 822,000 | 855,000 | 778,300 |
| Investments And Advances | 214,700 | 192,700 | 91,200 | 85,800 | 82,700 |
| Intangibles | 141,600 | 137,600 | 126,100 | 129,400 | 126,300 |
| Other Non-Current Assets | 120,600 | 113,100 | 45,200 | 49,100 | 87,500 |
| TOTAL | $1,420,100 | $1,282,700 | $1,084,500 | $1,119,300 | $1,074,800 |
| Total Assets | $2,793,800 | $2,341,400 | $1,978,900 | $1,862,800 | $1,716,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 213,100 | 156,800 | 130,400 | 138,100 | 122,000 |
| Accrued Expenses | 132,000 | 73,000 | 64,500 | 56,200 | 51,600 |
| Other current liabilities | 145,900 | 93,500 | 78,900 | 79,200 | 60,500 |
| TOTAL | $503,400 | $341,600 | $283,700 | $279,500 | $241,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 252,900 | 255,000 | 196,000 | 197,000 | 226,200 |
| Other Non-Current Liabilities | 149,700 | 138,300 | 89,800 | 96,000 | 122,800 |
| TOTAL | $435,900 | $426,600 | $298,900 | $303,400 | $358,200 |
| Total Liabilities | $939,300 | $768,200 | $582,600 | $582,900 | $599,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,103 | 73,837 | 74,186 | 73,987 | 73,260 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,400 |
| Retained earnings | 1,846,700 | 1,549,400 | 1,353,400 | 1,178,200 | 1,071,600 |
| Other shareholders' equity | -110,300 | -149,700 | -153,900 | -117,400 | -186,900 |
| TOTAL | $1,854,500 | $1,573,200 | $1,396,300 | $1,279,900 | $1,117,500 |
| Total Liabilities And Equity | $2,793,800 | $2,341,400 | $1,978,900 | $1,862,800 | $1,716,700 |